{"name":"Fletcher Spaght Ventures","permalink":"fletcher-spaght-ventures","crunchbase_url":"http://www.crunchbase.com/financial-organization/fletcher-spaght-ventures","homepage_url":"http://www.fletcherspaght.com/ventures/content.asp?pid=01_overview","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"617-247-6700","description":"Venture Capital Firm","email_address":"info@fletcherspaght.com","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Tue Dec 08 05:47:50 UTC 2009","updated_at":"Sat Sep 18 11:52:30 UTC 2010","overview":"<p>Fletcher Spaght Ventures, L.P. (FSV) is a venture capital firm investing in emerging growth healthcare and high technology companies. Differentiating it from other venture capital firms, FSV is able to leverage the strengths, experience and extensive VC and industry network of its partner consulting business, Fletcher Spaght, Inc. in identifying investment opportunities and providing post-investment support. </p>","image":{"available_sizes":[[[150,38],"assets/images/resized/0010/2158/102158v1-max-150x150.png"],[[250,64],"assets/images/resized/0010/2158/102158v1-max-250x250.png"],[[278,72],"assets/images/resized/0010/2158/102158v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"HQ","address1":"222 Berkeley Street","address2":"20th Floor","zip_code":"02116","city":"Boston","state_code":"MA","country_code":"USA","latitude":null,"longitude":null}],"relationships":[],"investments":[{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/metabolon-inc-series-c-6m/","source_description":"Metabolon, Inc.: Series C $6M","raised_amount":6000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":12,"funded_day":7,"company":{"name":"Metabolon","permalink":"metabolon","image":{"available_sizes":[[[150,26],"assets/images/resized/0006/8827/68827v1-max-150x150.png"],[[190,34],"assets/images/resized/0006/8827/68827v1-max-250x250.png"],[[190,34],"assets/images/resized/0006/8827/68827v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2010/01/phasebio-pharmaceuticals-raises.html","source_description":"PhaseBio Pharmaceuticals Raises $25M in Series B Funding Round","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":7,"company":{"name":"PhaseBio Pharmaceuticals","permalink":"phasebio-pharmaceuticals","image":{"available_sizes":[[[150,49],"assets/images/resized/0007/2629/72629v1-max-150x150.jpg"],[[193,64],"assets/images/resized/0007/2629/72629v1-max-250x250.jpg"],[[193,64],"assets/images/resized/0007/2629/72629v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://insidehpc.com/2007/10/24/interactive-supercomputing-raises-series-b-funding/","source_description":"Interactive Supercomputing Raises Series B Funding","raised_amount":11000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":10,"funded_day":24,"company":{"name":"Interactive Supercomputing","permalink":"interactive-supercomputing","image":{"available_sizes":[[[150,40],"assets/images/resized/0006/0498/60498v1-max-150x150.jpg"],[[223,60],"assets/images/resized/0006/0498/60498v1-max-250x250.jpg"],[[223,60],"assets/images/resized/0006/0498/60498v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://olv.duke.edu/About/News/20071025085536830","source_description":"Phase Bioscience raises $6.6 million","raised_amount":6600000,"raised_currency_code":"USD","funded_year":2007,"funded_month":10,"funded_day":24,"company":{"name":"PhaseBio Pharmaceuticals","permalink":"phasebio-pharmaceuticals","image":{"available_sizes":[[[150,49],"assets/images/resized/0007/2629/72629v1-max-150x150.jpg"],[[193,64],"assets/images/resized/0007/2629/72629v1-max-250x250.jpg"],[[193,64],"assets/images/resized/0007/2629/72629v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.htgenomics.com/htg-completes-first-tranche-of-157-million-series-d-financing-628.htm","source_description":"HTG Completes First Tranche of $15.7 Million Series D Financing","raised_amount":15700000,"raised_currency_code":"USD","funded_year":2011,"funded_month":2,"funded_day":23,"company":{"name":"High Throughput Genomics","permalink":"high-throughput-genomics","image":{"available_sizes":[[[150,86],"assets/images/resized/0012/3897/123897v1-max-150x150.jpg"],[[154,89],"assets/images/resized/0012/3897/123897v1-max-250x250.jpg"],[[154,89],"assets/images/resized/0012/3897/123897v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://finance.yahoo.com/news/CardioFocus-Inc-Raises-306-prnews-3740959625.html?x=0","source_description":"CardioFocus, Inc. Raises $30.6 Million in Private Financing","raised_amount":30600000,"raised_currency_code":"USD","funded_year":2011,"funded_month":2,"funded_day":28,"company":{"name":"CardioFocus","permalink":"cardiofocus","image":{"available_sizes":[[[150,67],"assets/images/resized/0012/4085/124085v1-max-150x150.jpg"],[[250,112],"assets/images/resized/0012/4085/124085v1-max-250x250.jpg"],[[322,145],"assets/images/resized/0012/4085/124085v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.finsmes.com/2011/06/htg-molecular-diagnostics-receives-500k-sr-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"HTG Molecular Diagnostics Receives $500k from SR One in Series D Financing","raised_amount":15700000,"raised_currency_code":"USD","funded_year":2011,"funded_month":2,"funded_day":24,"company":{"name":"HTG Molecular Diagnostics","permalink":"htg-molecular-diagnostics","image":{"available_sizes":[[[150,89],"assets/images/resized/0013/8983/138983v1-max-150x150.jpg"],[[150,89],"assets/images/resized/0013/8983/138983v1-max-250x250.jpg"],[[150,89],"assets/images/resized/0013/8983/138983v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2011/08/sironrx-therapeutics-closes-3-4m-series-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"SironRX Therapeutics Closes $3.4M Series A Funding","raised_amount":3400000,"raised_currency_code":"USD","funded_year":2011,"funded_month":8,"funded_day":16,"company":{"name":"SironRX Therapeutics","permalink":"sironrx-therapeutics","image":{"available_sizes":[[[144,53],"assets/images/resized/0014/9822/149822v1-max-150x150.jpg"],[[144,53],"assets/images/resized/0014/9822/149822v1-max-250x250.jpg"],[[144,53],"assets/images/resized/0014/9822/149822v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.finsmes.com/2011/08/metabolon-secures-13-1m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Metabolon Secures $13.1M in Series D Financing","raised_amount":13100000,"raised_currency_code":"USD","funded_year":2011,"funded_month":8,"funded_day":29,"company":{"name":"Metabolon","permalink":"metabolon","image":{"available_sizes":[[[150,26],"assets/images/resized/0006/8827/68827v1-max-150x150.png"],[[190,34],"assets/images/resized/0006/8827/68827v1-max-250x250.png"],[[190,34],"assets/images/resized/0006/8827/68827v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.bizjournals.com/phoenix/news/2012/02/14/scottsdales-cayenne-medical-lands.html","source_description":"Scottsdale's Cayenne Medical lands $10M in funding ","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":2,"funded_day":14,"company":{"name":"Cayenne Medical","permalink":"cayenne-medical","image":{"available_sizes":[[[150,61],"assets/images/resized/0017/4312/174312v1-max-150x150.png"],[[166,68],"assets/images/resized/0017/4312/174312v1-max-250x250.png"],[[166,68],"assets/images/resized/0017/4312/174312v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://pevc.dowjones.com/article?an=DJFVW00020120605e865tt70p&from=alert&pid=32&ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120605e865tt70p%26from%3dalert%26pid%3d32","source_description":"PhaseBio Pharmaceuticals Books $23M in Third Tranche of Series B ","raised_amount":23000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":6,"funded_day":5,"company":{"name":"PhaseBio Pharmaceuticals","permalink":"phasebio-pharmaceuticals","image":{"available_sizes":[[[150,49],"assets/images/resized/0007/2629/72629v1-max-150x150.jpg"],[[193,64],"assets/images/resized/0007/2629/72629v1-max-250x250.jpg"],[[193,64],"assets/images/resized/0007/2629/72629v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2012/07/juventas-therapeutics-closes-22-2m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Juventas Therapeutics Closes $22.2M Series B Financing","raised_amount":22200000,"raised_currency_code":"USD","funded_year":2012,"funded_month":7,"funded_day":16,"company":{"name":"Juventas Therapeutics","permalink":"juventas-therapeutics","image":{"available_sizes":[[[150,66],"assets/images/resized/0013/2328/132328v1-max-150x150.jpg"],[[196,87],"assets/images/resized/0013/2328/132328v1-max-250x250.jpg"],[[196,87],"assets/images/resized/0013/2328/132328v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}